Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
45.36
-0.17 (-0.37%)
At close: Mar 20, 2026, 4:00 PM EDT
45.34
-0.02 (-0.04%)
After-hours: Mar 20, 2026, 7:44 PM EDT
Royalty Pharma Market Cap
Royalty Pharma has a market cap or net worth of $19.43 billion as of March 20, 2026. Its market cap has increased by 34.75% in one year.
Market Cap
19.43B
Enterprise Value
27.77B
1-Year Change
34.75%
Ranking
Category
Stock Price
$45.36
Market Cap Chart
Since June 16, 2020, Royalty Pharma's market cap has increased from $15.76B to $19.43B, an increase of 23.30%. That is a compound annual growth rate of 3.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 19.43B | 17.71% |
| Dec 31, 2025 | 16.51B | 45.66% |
| Dec 31, 2024 | 11.33B | -9.30% |
| Dec 29, 2023 | 12.50B | -28.31% |
| Dec 30, 2022 | 17.43B | 1.85% |
| Dec 31, 2021 | 17.12B | -11.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 31.34B |
| Insmed | 31.04B |
| BioNTech SE | 22.45B |
| Moderna | 20.68B |
| Roivant Sciences | 19.90B |
| Revolution Medicines | 19.68B |
| Incyte | 18.50B |
| Genmab | 15.59B |